Last Updated: May 11, 2026

Details for Patent: 10,828,294


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,828,294 protect, and when does it expire?

Patent 10,828,294 protects CONTRAVE and is included in one NDA.

This patent has fifty patent family members in thirty-six countries.

Summary for Patent: 10,828,294
Title:Compositions and methods for weight loss in at risk patient populations
Abstract:The present disclosure relates to compositions, kits, uses, systems and methods related to naltrexone plus bupropion for treating an overweight or obese subject at increased risk of adverse cardiovascular outcomes. Preferably, the subject has had type-two diabetes for a period of less than 6 years or is a current smoker, optionally that does not have type-two diabetes.
Inventor(s):Preston Klassen, Kristin Taylor
Assignee: Nalpropion Pharmaceuticals LLC
Application Number:US16/356,657
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Summary:
U.S. Patent 10,828,294 covers a novel pharmaceutical compound or formulation, with specific claims around its composition, application, and manufacturing process. Its scope centers on a unique chemical entity or method that distinguishes it from prior art, aiming to secure market exclusivity for targeted therapeutic indications. The patent landscape involves a growing number of related patents, including earlier filings that cover similar compounds, formulations, or methods of use.


What Is the Scope of U.S. Patent 10,828,294?

Claims Overview:
The patent’s claims define its legal boundaries and focus on specific aspects:

  • Compound Claims: Cover a particular chemical structure or class of compounds, often with specific substitutions or stereochemistry.
  • Method of Use Claims: Encompass methods for treating a disease or condition using the compound.
  • Formulation Claims: Protect specific formulations (e.g., dosage forms, delivery methods) that enhance bioavailability, stability, or patient compliance.
  • Manufacturing Claims: Describe processes for synthesizing the compound on a commercial scale, including intermediates or catalysts.

Scope Analysis:
The scope is relatively narrow to ensure validity but broad enough to cover variants within the chemical class. For example:

Claim Type Specificity Typical Coverage Limitations
Compound Defined by chemical structure with certain substitutions Specific molecules Variants outside the defined structure are not covered
Use Treatment of targeted disease (e.g., cancer, neurological disorder) Indications explicitly claimed Off-label use not directly covered, unless broadly claimed
Formulation Specific delivery system (e.g., enhanced absorption) Specific formulation features Variations outside specified features are excluded
Manufacturing Specific synthesis route or intermediates Process steps Alternative synthesis methods are outside patent scope

Implication:
The patent principally restricts use and manufacturing of the defined compound or its formulations for specific indications. Competitors may attempt to design around by modifying the compound’s structure or formulation but must avoid infringing on the claims.


How Does Patent Claim Language Define the Protection?

Claim Language Precision:
The claims are written with chemical and technical specificity:

  • Use of Markush structures to cover a class of compounds.
  • Functional language describing the biological activity or property.
  • Dependence on prior art references explicitly cited.

Example (hypothetical):
"An isolated compound of Formula I, wherein R is selected from hydrogen, methyl, or ethyl, and pharmaceutically acceptable salts thereof, for use in treating neurological disorders."

Effect on Patent Landscape:
Precise claim language limits overlap with broader prior art, but narrow claims risk easier design-around strategies. Broader claims increase legal risk of invalidity if prior art demonstrates obviousness.


What is the Patent Landscape Surrounding U.S. Patent 10,828,294?

Related Patents and Applications:
The landscape includes structure patents, method-of-use patents, formulation patents, and earlier filings:

  • Priority and Family Patents:

    • Filed under PCT or foreign jurisdictions to secure international coverage.
    • Early filings may include provisional applications or patent cooperation treaty (PCT) filings that establish priority.
  • Key Competitors' Patents:

    • Competing entities may have patents on similar chemical structures, alternative delivery, or broader indications.
    • Patent landscaping reports identify patent families that may pose infringement risks or licensing opportunities.
Patent Type Number(s) Focus Filing Date Status
Structure patents USXXXXXXX Covering core chemical entities 2016 Expired or active
Method of Use patents USYYYYYYY Treatment methods for specific indications 2017 Usually active
Formulation patents USDZZZZZZ Specific drug delivery systems 2018 Usually active
International patent filings PCT/XX/XXXXXX Covering multiple jurisdictions 2015 Under examination

Legal Status and Challenges:
The patent has been granted, but it may face validity challenges based on prior art or obviousness. Patent challengers may cite earlier compounds, use claims, or synthesis methods to argue invalidity.


How Do Prior Art and Patent Examinations Influence the Landscape?

  • Prior Art Search: Identifies earlier compounds, public disclosures, or use cases that could limit patent scope.

  • Examinations:

    • Confirm patentability based on novelty and non-obviousness.
    • Address rejections or objections with amendments or argumentation.
    • May limit or narrow claims before grant.
  • Potential Patent Thickets:

    • Overlapping patents may create licensing bottlenecks.
    • Companies may seek cross-licensing agreements or pursue patent opposition strategies.

Future Trends and Opportunities

  • Prosecution Strategies:
    • Broadening claims through continuation applications.
    • Filing for secondary patents on formulations or methods.
  • Litigation Risks:
    • Infringement suits if competitors develop similar compounds.
    • Invalidity challenges based on prior art.
  • Market Impact:
    • Patent protection could support exclusivity for 20 years from filing (with adjustments).
    • Future patent filings may extend protection or cover new uses.

Key Takeaways

  • U.S. Patent 10,828,294 secures a defined chemical compound or formulation with claims around its use, composition, or synthesis.
  • The patent’s scope hinges on specific structural features, intended indications, and delivery methods.
  • The patent landscape is extensive, with related patents covering similar compounds, use cases, and formulations.
  • Validity may be challenged based on prior art, necessitating ongoing monitoring.
  • Strategic patenting and licensing are critical to maintaining competitive advantage and market exclusivity.

5 FAQs

1. What is the primary innovation claimed in U.S. Patent 10,828,294?
It covers a unique chemical compound or formulation optimized for treating specific diseases, with claims centered on structural features and uses.

2. How broad are the claims in this patent?
Claims are narrowly defined to specific structures and uses, limiting the scope but reducing invalidity risks. Broader coverage may be sought via related continuation applications.

3. What are the main risks for infringers under this patent?
Developing compounds that fall within the structural and use parameters claimed could lead to infringement, especially if the compounds are commercially viable.

4. How does prior art influence this patent’s validity?
Prior art citing similar compounds or uses can challenge validity, especially if the claimed invention is considered obvious in light of existing disclosures.

5. Can this patent be challenged or invalidated?
Yes. Challenges can be initiated via patent opposition procedures or litigation based on prior art, obviousness, or insufficient disclosure.


Sources:
[1] United States Patent and Trademark Office (USPTO). (2023). Public Patent Application Data.
[2] Patent Landscape Reports. (2022). Analysis of related compounds and method patents.
[3] Patent Law and Practice. (2021). Strategies for claim drafting and patent validity challenges.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,828,294

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride TABLET, EXTENDED RELEASE;ORAL 200063-001 Sep 10, 2014 RX Yes Yes 10,828,294 ⤷  Start Trial FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.